ROXITHROMYCIN IN THE THERAPY OF STREPTOCOCCUS-PYOGENES THROAT INFECTIONS

被引:11
作者
HERRON, JM
机构
关键词
D O I
10.1093/jac/20.suppl_B.139
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:139 / 144
页数:6
相关论文
共 5 条
[1]   INVITRO COMPARISON OF THE ACTIVITY OF RU-28965, A NEW MACROLIDE, WITH THAT OF ERYTHROMYCIN AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
BARLAM, T ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :529-531
[2]   ANTIBACTERIAL ACTIVITY OF ROXITHROMYCIN - A LABORATORY EVALUATION [J].
CHANTOT, JF ;
BRYSKIER, A ;
GASC, JC .
JOURNAL OF ANTIBIOTICS, 1986, 39 (05) :660-668
[3]   DISK DIFFUSION SUSCEPTIBILITY TESTING OF 2-MACROLIDE ANTIMICROBIAL AGENTS - REVISED INTERPRETIVE CRITERIA FOR ERYTHROMYCIN AND PRELIMINARY GUIDELINES FOR ROXITHROMYCIN (RU 965) [J].
JONES, RN ;
BARRY, AL ;
FUCHS, PC ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (02) :233-239
[4]  
SULLIVAN D, 1980, JAMA-J AM MED ASSOC, V243, P1074
[5]  
VITERI AL, 1979, GASTROENTEROLOGY, V76, P1007